meteor asisten Mengilhami erc psallidas ioannis Kontribusi faktor Lima
PDF) Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual ...
Observation of a new excited beauty strange baryon decaying to $\Xi_{\mathrm{b}}^{-}\pi^{+}\pi^{-}$ - CERN Document Server
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. - Abstract - Europe PMC
Osteopontin is upregulated in malignant and inflammatory pleural effusions - MOSCHOS - 2009 - Respirology - Wiley Online Library
Amsterdam 2015 ERS International Congress Programme Education and Scientific sessions organised by ERS Saturday 26 September 201
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.,The Lancet Respiratory Medicine - X-MOL
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.,The Lancet Respiratory Medicine - X-MOL
Table of Contents — August 01, 2019, 54 (2) | European Respiratory Society
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
70+ "Ioannis M.d" profiles | LinkedIn
Ioannis Psallidas, CISSP, CISA, CRISC, COBIT5F - Director-Assurance of Infrastructures and Privacy of Services and Internet Applications Division - Hellenic Authority for Communication Security and Privacy | LinkedIn
Supplemental Materials for Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis - The Lancet Oncology
ERS International Congress 2017 - Program by Margaritidis Audio Visual - issuu
Malignant pleural effusion: from bench to bedside.” Ioannis Psallidas, Ioannis Kalomenidis, Jose M. Porcel, Bruce W. Robinson and Georgios T. Stathopoulos. Eur Respir Rev 2016; 25: 189–198. | European Respiratory Society
PDF) Osteopontin is not a specific marker in malignant pleural mesothelioma
Measurement of quark- and gluon-like jet fractions using jet charge in PbPb and pp collisions at 5.02 TeV - CERN Document Server
Chemokine (C‐C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient‐based study - Xu - 2015 - Cancer Science - Wiley Online Library
i>NRAS</i> destines tumor cells to the lungs. - Abstract - Europe PMC
PDF) The management of benign non-infective pleural effusions
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. - Abstract - Europe PMC
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory - Page 3
CONGRESS GUIDE
Ioannis Psallidas | hosco.
PDF) Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma